Myovant Sciences Ltd. (MYOV) Q3 2021 Earnings Call Transcript
At this time, I'd like to turn the call over to Ryan Crowe, vice president of investor relations at Myovant. Good morning and thanks for joining us today to review the financial results of Myovant's third quarter of fiscal year 2021 and to discuss other corporate and business updates. Joining me for today's call, are David Marek, Myovant's chief executive officer; Uneek Mehra, chief financial and business officer; Lauren Merendino, chief commercial officer; and Dr. Juan Camilo Arjona, chief medical officer.
